Regeneron Pharmaceuticals (NASDAQ:REGN) just disclosed its Q4 earnings on Friday, January 30, 2026 at 06:30 AM.
Here’s a brief overview of the earnings report.
Earnings
Regeneron Pharmaceuticals beat estimated earnings by 18.0%, reporting an EPS of $11.44 versus an estimate of $9.69.
Revenue was up $95.00 million from the same period last year.
Earnings History Overview
The company beat on EPS by …